Use of Polybiolin drug in patients with liver cirrhosis

摘要

The invention relates to medicine, namely to the use of Polybiolin drug in patients with liver cirrhosis, wherein the drug is administered intramuscularly, in a dose of 500 mg, for 8…10 days.